Form 8-K - Current report:
SEC Accession No. 0001104659-25-027545
Filing Date
2025-03-25
Accepted
2025-03-25 07:30:22
Documents
16
Period of Report
2025-03-25
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2510212d1_8k.htm   iXBRL 8-K 27077
2 EXHIBIT 99.1 tm2510212d1_ex99-1.htm EX-99.1 21175
3 EXHIBIT 99.2 tm2510212d1_ex99-2.htm EX-99.2 759
7 GRAPHIC tm2510212d1_ex99-2img01.jpg GRAPHIC 791943
  Complete submission text file 0001104659-25-027545.txt   1319960

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA tmb-20250325.xsd EX-101.SCH 3012
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE tmb-20250325_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tmb-20250325_pre.xml EX-101.PRE 22358
18 EXTRACTED XBRL INSTANCE DOCUMENT tm2510212d1_8k_htm.xml XML 3553
Mailing Address 12 PENNS TRAIL NEWTOWN PA 18940
Business Address 12 PENNS TRAIL NEWTOWN PA 18940 267-759-3680
Traws Pharma, Inc. (Filer) CIK: 0001130598 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36020 | Film No.: 25765858
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)